DNA X, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-20.7M | $-33.6M | $-90.0K | $-14.1M | $-38.6M | $-29.9M | $-25.8M | $1.3M |
| Depreciation & Amortization | $4.3M | $3.6M | $2.2M | $2.4M | $2.1M | $2.7M | $3.5M | $1.9M |
| Depreciation | — | $58.0K | $47.0K | $244.0K | $301.0K | $426.0K | $621.0K | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.5M | $1.5M | $1.5M | $1.6M | $1.1M | $1.1M | $6.3M | $252.0K |
| Net Cash from Operating Activities | $-23.5M | $-8.5M | $-4.1M | $-12.4M | $-38.5M | $-10.6M | $-33.5M | $3.9M |
| Investing Activities | ||||||||
| Capital Expenditures | — | $214.0K | $36.0K | $8.0K | $46.0K | $11.0K | $992.0K | $787.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-214.0K | $-36.0K | $-8.0K | $-46.0K | $-11.0K | $-1.4M | $-2.5M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $19.5M | $4.6M | $272.0K | $14.3M | $27.6M | $21.4M | $33.1M | $10.2M |
| Net Change in Cash | $-4.0M | $-4.1M | $-3.8M | $2.0M | $-10.9M | $10.8M | $-1.8M | $11.5M |
| Free Cash Flow | — | $-8.7M | $-4.1M | $-12.4M | $-38.5M | $-10.6M | $-34.5M | $3.1M |